You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Circulating Tumor Cells: Liquid Biopsy of Cancer
|
|---|---|
| Published in |
Clinical Chemistry, January 2013
|
| DOI | 10.1373/clinchem.2012.194258 |
| Pubmed ID | |
| Authors |
Catherine Alix-Panabières, Klaus Pantel |
| Abstract |
The detection and molecular characterization of circulating tumor cells (CTCs) are one of the most active areas of translational cancer research, with >400 clinical studies having included CTCs as a biomarker. The aims of research on CTCs include (a) estimation of the risk for metastatic relapse or metastatic progression (prognostic information), (b) stratification and real-time monitoring of therapies, (c) identification of therapeutic targets and resistance mechanisms, and (d) understanding metastasis development in cancer patients. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 57% |
| Russia | 1 | 14% |
| Unknown | 2 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 57% |
| Scientists | 3 | 43% |
Mendeley readers
The data shown below were compiled from readership statistics for 826 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | <1% |
| Germany | 2 | <1% |
| India | 2 | <1% |
| Turkey | 1 | <1% |
| Malaysia | 1 | <1% |
| Portugal | 1 | <1% |
| Brazil | 1 | <1% |
| Canada | 1 | <1% |
| Ireland | 1 | <1% |
| Other | 4 | <1% |
| Unknown | 806 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 163 | 20% |
| Student > Master | 137 | 17% |
| Researcher | 121 | 15% |
| Student > Bachelor | 89 | 11% |
| Student > Doctoral Student | 42 | 5% |
| Other | 118 | 14% |
| Unknown | 156 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 170 | 21% |
| Medicine and Dentistry | 128 | 15% |
| Agricultural and Biological Sciences | 123 | 15% |
| Engineering | 99 | 12% |
| Chemistry | 27 | 3% |
| Other | 95 | 12% |
| Unknown | 184 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2023.
All research outputs
#1,626,384
of 23,299,593 outputs
Outputs from Clinical Chemistry
#205
of 7,475 outputs
Outputs of similar age
#15,845
of 283,605 outputs
Outputs of similar age from Clinical Chemistry
#5
of 54 outputs
Altmetric has tracked 23,299,593 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,475 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,605 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.